{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:03:17Z","timestamp":1791572597965,"version":"4.3.4"},"reference-count":52,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFA1800100"],"award-info":[{"award-number":["2023YFA1800100"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020084","name":"Guangzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["2024A03J1021"],"award-info":[{"award-number":["2024A03J1021"]}],"id":[{"id":"10.13039\/501100020084","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010842","name":"Guangzhou Municipal Health Commission","doi-asserted-by":"publisher","award":["20241A011012"],"award-info":[{"award-number":["20241A011012"]}],"id":[{"id":"10.13039\/501100010842","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010842","name":"Guangzhou Municipal Health Commission","doi-asserted-by":"publisher","award":["2019GX04"],"award-info":[{"award-number":["2019GX04"]}],"id":[{"id":"10.13039\/501100010842","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010842","name":"Guangzhou Municipal Health Commission","doi-asserted-by":"publisher","award":["2023C-GX01"],"award-info":[{"award-number":["2023C-GX01"]}],"id":[{"id":"10.13039\/501100010842","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jtct.2025.06.014","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T02:59:17Z","timestamp":1749697157000},"page":"808.e1-808.e13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Comparative Study of Bu\/Cy\/ATG and Flu\/Cy\/ATG Conditioning Regimens for Unrelated Donor Hematopoietic Stem Cell Transplantation in Severe Aplastic Anemia"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9178-8440","authenticated-orcid":false,"given":"Liangliang","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2324-673X","authenticated-orcid":false,"given":"Xiaowei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1766-3084","authenticated-orcid":false,"given":"Wenjian","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9650-2758","authenticated-orcid":false,"given":"Ruiqing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caixia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyi","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingfen","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5761-1633","authenticated-orcid":false,"given":"Yuling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9418-4901","authenticated-orcid":false,"given":"Shunqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.jtct.2025.06.014_bib0001","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1056\/NEJMra1413485","article-title":"Aplastic Anemia","volume":"379","author":"Young","year":"2018","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jtct.2025.06.014_bib0002","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/bjh.13853","article-title":"Guidelines for the diagnosis and management of adult aplastic anaemia","volume":"172","author":"Killick","year":"2016","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.jtct.2025.06.014_bib0003","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s12185-015-1881-2","article-title":"Impairment of hematopoietic stem cell niches in patients with aplastic anemia","volume":"102","author":"Wu","year":"2015","journal-title":"Int J Hematol"},{"issue":"1","key":"10.1016\/j.jtct.2025.06.014_bib0004","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41408-024-01021-x","article-title":"Unrelated donor hematopoietic stem cell transplantation compared to immunosuppressive therapy plus eltrombopag as first-line treatment for adults with severe aplastic anemia","volume":"14","author":"Wu","year":"2024","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.jtct.2025.06.014_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2024.09.017","article-title":"Allogeneic hematopoietic cell transplantation for the treatment of severe aplastic anemia: evidence-based guidelines from the american society for transplantation and cellular therapy","author":"Iftikhar","year":"2024","journal-title":"Transplant Cell Ther"},{"issue":"3","key":"10.1016\/j.jtct.2025.06.014_bib0006","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/bjh.19236","article-title":"Guidelines for the diagnosis and management of adult aplastic anaemia: a British society for haematology guideline","volume":"204","author":"Kulasekararaj","year":"2024","journal-title":"Br J Haematol"},{"issue":"9","key":"10.1016\/j.jtct.2025.06.014_bib0007","doi-asserted-by":"crossref","first-page":"e277","DOI":"10.1016\/j.bbmt.2019.05.012","article-title":"The case for upfront HLA-matched unrelated donor hematopoietic stem cell transplantation as a curative option for adult acquired severe aplastic anemia","volume":"25","author":"Marsh","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"10.1016\/j.jtct.2025.06.014_bib0008","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.hoc.2018.03.004","article-title":"Upfront matched unrelated donor transplantation in aplastic anemia","volume":"32","author":"Clesham","year":"2018","journal-title":"Hematolo\/oncol Clin North Am"},{"issue":"11","key":"10.1016\/j.jtct.2025.06.014_bib0009","article-title":"Efficacy of a modified post-transplant cyclophosphamide regimen for unrelated donor hematopoietic stem cell transplantation in patients with severe aplastic anemia: a prospective Study","volume":"30","author":"Chen","year":"2024","journal-title":"Transplant Cell Ther"},{"issue":"3","key":"10.1016\/j.jtct.2025.06.014_bib0010","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1182\/blood.2024024173","article-title":"Alternative donor transplantation for severe aplastic anemia: a comparative study of the SAAWP EBMT","volume":"144","author":"Montoro","year":"2024","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.jtct.2025.06.014_bib0011","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1182\/bloodadvances.2019000722","article-title":"Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia","volume":"3","author":"Bejanyan","year":"2019","journal-title":"Blood Advances"},{"issue":"11","key":"10.1016\/j.jtct.2025.06.014_bib0012","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/sj.bmt.1704720","article-title":"cyclophosphamide plus thymoglobulin conditioning regimen for unrelated bone marrow transplantation in severe aplastic anemia","volume":"34","author":"Kang","year":"2004","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1016\/j.jtct.2025.06.014_bib0013","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.bbmt.2016.04.003","article-title":"Improved outcome of a reduced toxicity-fludarabine, cyclophosphamide, plus antithymocyte globulin conditioning regimen for unrelated donor transplantation in severe aplastic anemia: comparison of 2 multicenter prospective studies","volume":"22","author":"Kang","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"10.1016\/j.jtct.2025.06.014_bib0014","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/sj.bmt.1705165","article-title":"Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working Party","volume":"36","author":"Bacigalupo","year":"2005","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"10.1016\/j.jtct.2025.06.014_bib0015","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.bbmt.2010.05.010","article-title":"Successful engraftment with fludarabine, cyclophosphamide, and thymoglobulin conditioning regimen in unrelated transplantation for severe aplastic anemia: A phase II prospective multicenter study","volume":"16","author":"Kang","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.06.014_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102819","article-title":"Long-term survival after unrelated donor marrow transplantation for aplastic anaemia after optimized conditioning regimen: a retrospective multicentre cohort study","volume":"76","author":"Eapen","year":"2024","journal-title":"EClinicalMedicine"},{"issue":"9","key":"10.1016\/j.jtct.2025.06.014_bib0017","doi-asserted-by":"crossref","first-page":"e367","DOI":"10.1016\/S2352-3026(15)00147-7","article-title":"Cyclophosphamide conditioning in patients with severe aplastic anaemia given unrelated marrow transplantation: a phase 1-2 dose de-escalation study","volume":"2","author":"Anderlini","year":"2015","journal-title":"The Lancet Haematology"},{"issue":"Suppl 2","key":"10.1016\/j.jtct.2025.06.014_bib0018","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/s41409-019-0605-2","article-title":"Update of the \u201cBeijing Protocol\u201d haplo-identical hematopoietic stem cell transplantation","volume":"54","author":"Lv","year":"2019","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"10.1016\/j.jtct.2025.06.014_bib0019","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1038\/bmt.2012.79","article-title":"A novel protocol for haploidentical hematopoietic SCT without in vitro T-cell depletion in the treatment of severe acquired aplastic anemia","volume":"47","author":"Xu","year":"2012","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1016\/j.jtct.2025.06.014_bib0020","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.bbmt.2019.03.020","article-title":"Comparable outcomes of first-line hematopoietic stem cell transplantation from unrelated and matched sibling donors in adult patients with aplastic anemia: a retrospective single-center study","volume":"25","author":"Zhang","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"10.1016\/j.jtct.2025.06.014_bib0021","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1007\/s00277-021-04540-w","article-title":"Optimizing conditioning regimen with low-dose irradiation or busulfan enables the outcome of transplantation from a 6-7\/8 HLA-matched donor comparable to that from an 8\/8 HLA-matched unrelated donor in severe aplastic anemia patients under 40 years","volume":"100","author":"Qin","year":"2021","journal-title":"Annals of hematology"},{"issue":"1","key":"10.1016\/j.jtct.2025.06.014_bib0022","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13045-017-0398-y","article-title":"Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant","volume":"10","author":"Xu","year":"2017","journal-title":"J Hematol Oncol"},{"issue":"1","key":"10.1016\/j.jtct.2025.06.014_bib0023","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.gendis.2023.03.027","article-title":"Predictive value of T cell receptor repertoire profiling for immunosuppressive therapy in severe aplastic anemia","volume":"11","author":"Chen","year":"2024","journal-title":"Genes Diseases"},{"issue":"12","key":"10.1016\/j.jtct.2025.06.014_bib0024","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"issue":"12","key":"10.1016\/j.jtct.2025.06.014_bib0025","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1016\/j.bbmt.2018.07.018","article-title":"Allogeneic hematopoietic stem cell transplantation for the treatment of severe aplastic anemia patients with infection: a single-center retrospective study","volume":"24","author":"Xu","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"10.1016\/j.jtct.2025.06.014_bib0026","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1038\/bmt.2013.84","article-title":"Reduced PTLD-related mortality in patients experiencing EBV infection following allo-SCT after the introduction of a protocol incorporating pre-emptive rituximab","volume":"48","author":"van der Velden","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2025.06.014_bib0027","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s12886-017-0622-0","article-title":"High ocular CMV copies and mismatched receipts may predict poor visual prognosis in CMV retinitis patients following allogeneic haematopoietic stem cell transplantation","volume":"17","author":"Zhang","year":"2017","journal-title":"BMC Ophthalmol"},{"issue":"4","key":"10.1016\/j.jtct.2025.06.014_bib0028","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/sj.bmt.1705727","article-title":"Competing risk analysis using R: an easy guide for clinicians","volume":"40","author":"Scrucca","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"10.1016\/j.jtct.2025.06.014_bib0029","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/aje\/kwh090","article-title":"A modified Poisson regression approach to prospective studies with binary data","volume":"159","author":"Zou","year":"2004","journal-title":"American journal of epidemiology"},{"issue":"9","key":"10.1016\/j.jtct.2025.06.014_bib0030","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1007\/s00277-019-03742-7","article-title":"Risk factors and clinical outcomes of Epstein\u2013Barr virus DNAemia and post-transplant lymphoproliferative disorders after haploidentical and matched-sibling PBSCT in patients with hematologic malignancies","volume":"98","author":"Gao","year":"2019","journal-title":"Annals hematol"},{"issue":"10","key":"10.1016\/j.jtct.2025.06.014_bib0031","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/bmt.2008.394","article-title":"Prior immunosuppressive therapy with antithymocyte globulin increases the risk of EBV-related lymphoproliferative disorder following allo-SCT for acquired aplastic anaemia","volume":"43","author":"Buyck","year":"2009","journal-title":"Bone Marrow Transplant"},{"issue":"14","key":"10.1016\/j.jtct.2025.06.014_bib0032","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1002\/sim.7273","article-title":"Firth's logistic regression with rare events: accurate effect estimates and predictions?","volume":"36","author":"Puhr","year":"2017","journal-title":"Statis med"},{"issue":"2","key":"10.1016\/j.jtct.2025.06.014_bib0033","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/sj.bmt.1702768","article-title":"A fludarabine-based conditioning regimen for severe aplastic anemia","volume":"27","author":"Chan","year":"2001","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2025.06.014_bib0034","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3109\/10428194.2010.524328","article-title":"Fludarabine, cyclophosphamide, and antithymocyte globulin for matched related and unrelated allogeneic stem cell transplant in severe aplastic anemia","volume":"52","author":"Anderlini","year":"2011","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"10.1016\/j.jtct.2025.06.014_bib0035","doi-asserted-by":"crossref","first-page":"976","DOI":"10.3324\/haematol.2009.018267","article-title":"Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA Working Party","volume":"95","author":"Bacigalupo","year":"2010","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.jtct.2025.06.014_bib0036","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1080\/17474086.2021.1923475","article-title":"Optimizing outcomes for haploidentical hematopoietic stem cell transplantation in severe aplastic anemia with intensive GVHD prophylaxis: a review of current findings","volume":"14","author":"Xu","year":"2021","journal-title":"Expert Rev Hematol"},{"issue":"5","key":"10.1016\/j.jtct.2025.06.014_bib0037","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1182\/blood-2006-03-005041","article-title":"Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy","volume":"108","author":"Deeg","year":"2006","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.jtct.2025.06.014_bib0038","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.leukres.2014.01.002","article-title":"Allogeneic hematopoietic cell transplantation without total body irradiation from unrelated donor in adult patients with idiopathic aplastic anemia: fludarabine versus cyclophosphamide-ATG","volume":"38","author":"Kim","year":"2014","journal-title":"Leuk Res"},{"issue":"2","key":"10.1016\/j.jtct.2025.06.014_bib0039","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/bjh.14225","article-title":"Haplo-identical transplantation for acquired severe aplastic anaemia in a multicentre prospective study","volume":"175","author":"Xu","year":"2016","journal-title":"Br J Haematol"},{"issue":"12","key":"10.1016\/j.jtct.2025.06.014_bib0040","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1038\/bmt.2014.187","article-title":"Good outcome of haploidentical hematopoietic SCT as a salvage therapy in children and adolescents with acquired severe aplastic anemia","volume":"49","author":"Wang","year":"2014","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"10.1016\/j.jtct.2025.06.014_bib0041","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1038\/s41409-022-01682-x","article-title":"Bulsufan decreases the incidence of mixed chimaerism in HLA-matched donor transplantation for severe aplastic anaemia","volume":"57","author":"Xu","year":"2022","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2025.06.014_bib0042","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/sj.bmt.1704325","article-title":"Addition of low-dose busulfan to cyclophosphamide in aplastic anemia patients prior to allogeneic bone marrow transplantation to reduce rejection","volume":"33","author":"Dulley","year":"2004","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.jtct.2025.06.014_bib0043","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/bmt.2009.311","article-title":"The inferiority of G-PB to rhG-CSF-mobilized blood and marrow grafts as a stem cell source in patients with high-risk acute leukemia who underwent unmanipulated HLA-mismatched\/haploidentical transplantation: a comparative analysis","volume":"45","author":"Xu","year":"2010","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jtct.2025.06.014_bib0044","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.bbmt.2018.09.004","article-title":"Peripheral blood versus bone marrow from unrelated donors: bone marrow allografts have improved long-term overall and graft-versus-host disease-free, relapse-free survival","volume":"25","author":"Alousi","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2025.06.014_bib0045","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/jmv.24989","article-title":"Serologic and viral genome prevalence of HSV, EBV, and HCMV among healthy adults in Wuhan, China","volume":"90","author":"Wen","year":"2018","journal-title":"J Med Virol"},{"issue":"1","key":"10.1016\/j.jtct.2025.06.014_bib0046","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12985-019-1123-y","article-title":"Immune reconstitution of HLA-A*0201\/BMLF1- and HLA-A*1101\/LMP2-specific Epstein Barr virus cytotoxic T lymphocytes within 90 days after haploidentical hematopoietic stem cell transplantation","volume":"16","author":"Zhou","year":"2019","journal-title":"Virol J"},{"issue":"1","key":"10.1016\/j.jtct.2025.06.014_bib0047","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s10238-023-01270-3","article-title":"Early T-cell reconstitution predicts risk of EBV reactivation after allogeneic hematopoietic stem cell transplantation","volume":"24","author":"Huang","year":"2024","journal-title":"Clin Exp Med"},{"issue":"7","key":"10.1016\/j.jtct.2025.06.014_bib0048","doi-asserted-by":"crossref","first-page":"884","DOI":"10.3324\/haematol.2015.138727","article-title":"Unrelated alternative donor transplantation for severe acquired aplastic anemia: a study from the French Society of Bone Marrow Transplantation and Cell Therapies and the EBMT Severe Aplastic Anemia Working Party","volume":"101","author":"Devillier","year":"2016","journal-title":"Haematologica"},{"issue":"19","key":"10.1016\/j.jtct.2025.06.014_bib0049","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10194416","article-title":"Fludarabine-cyclophosphamide-based conditioning with antithymocyte globulin serotherapy is associated with durable engraftment and manageable infections in children with severe aplastic anemia","volume":"10","author":"Salamonowicz-Bodzioch","year":"2021","journal-title":"J Clin Med"},{"issue":"7","key":"10.1016\/j.jtct.2025.06.014_bib0050","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1182\/blood.V87.7.3045.bloodjournal8773045","article-title":"Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation","volume":"87","author":"Sanders","year":"1996","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jtct.2025.06.014_bib0051","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41409-025-02520-6","article-title":"Impact of haematopoietic stem cell transplantation for benign and malignant haematologic and non-haematologic disorders on fertility: a systematic review and meta-analysis","volume":"60","author":"Vidal","year":"2025","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"10.1016\/j.jtct.2025.06.014_bib0052","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/bmt.2017.21","volume":"52","author":"Dalle","year":"2017","journal-title":"Bone Marrow Transplant"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725012588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725012588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T03:38:15Z","timestamp":1790825895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636725012588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":52,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S2666636725012588"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2025.06.014","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative Study of Bu\/Cy\/ATG and Flu\/Cy\/ATG Conditioning Regimens for Unrelated Donor Hematopoietic Stem Cell Transplantation in Severe Aplastic Anemia","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2025.06.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}